Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 12/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 11/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7014109 | 0.91 | ADRA2A (0.32) | CYP3A4 | |
| SCHEMBL8804674 | 0.86 | CARM1 (0.34) | KAT2BKCNH2 | |
| SCHEMBL9138352 | 0.86 | BACE1 (0.37) | SLC6A4KAT2BSLC6A3SLC6A2CYP2D6 | |
| SCHEMBL9139815 | 0.86 | PTGS2 (0.34) | KAT2B | |
| SCHEMBL8804858 | 0.86 | CYP2D6 (0.36) | SLC6A4KAT2BSLC6A3SLC6A2CYP2D6 | |
| SCHEMBL8175851 | 0.85 | KAT2B (0.33) | SLC6A4KAT2B | |
| SCHEMBL8806161 | 0.84 | GRIA2 (0.33) | KCNH2 | |
| SCHEMBL9138413 | 0.84 | DRD3 (0.40) | KCNH2 | |
| SCHEMBL8184837 | 0.84 | SLC6A4 (0.37) | SLC6A4KAT2BSLC6A3SLC6A2 | |
| SCHEMBL9139885 | 0.83 | HTR1A (0.33) | SLC6A4KAT2BCYP2D6CYP3A4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6028073-A | N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics | BASF AKTIENGESELLSCHAFT (DE) | 2000-02-22 | — | — | US | disclosed |
| EP-0775135-A1 | N-SUBSTITUTED 3-AZABICYCLO (3.2.0)HEPTANE DERIVATIVES USEFUL AS NEUROLEPTICS | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996004272-A1 | N-SUBSTITUTED 3-AZABICYCLO (3.2.0)HEPTANE DERIVATIVES USEFUL AS NEUROLEPTICS | BASF AKTIENGESELLSCHAFT (DE) | 1996-02-15 | — | — | WO | disclosed |